Shree Ganesh Remedies share news, announcements and annual reports
NSE: SGRLBSE: 540737Pharmaceuticals & BiotechnologySmall Cap
Shree Ganesh Remedies Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 2017
Last close ₹617.25down ₹22.50 (3.52%)BSE ₹617.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹639.75.
30 Oct: open ₹639.75, high ₹651.85, low ₹610.00
52-week range of BSE trades to 30 Oct 2026
₹381.10Low, 27 Jan 2026₹759.00High, 24 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹792 Cr1,715th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 65.44
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.78
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.16
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,62259.3% delivered
Shree Ganesh Remedies board meetings
119 filed, newest first. Page 2 of 3.
Jan 2024
Nov 2023
10 Nov · Board meeting
1 Nov · Board meeting
Meeting on 10 Nov 2023: quarterly results
Jul 2023
24 Jul · Board meeting
Meeting on 31 Jul 2023: quarterly results
May 2023
Apr 2023
26 Apr · Board meeting
Meeting on 30 May 2023: final dividend and audited results
Feb 2023
28 Feb · Board meeting
Meeting on 28 Feb 202328 Feb · Board meeting
Jan 2023
24 Jan · Board meeting
20 Jan · Board meeting
Meeting on 24 Jan 2023: rights issue10 Jan · Board meeting
Meeting on 16 Jan 2023: quarterly results
Oct 2022
17 Oct · Board meeting
Meeting on 23 Oct 2022: quarterly results
Jul 2022
4 Jul · Board meeting
Meeting on 12 Jul 2022: quarterly results
May 2022
6 May · Board meeting
Apr 2022
27 Apr · Board meeting
Meeting on 6 May 2022: audited results, final dividend and dividend
Feb 2022
2 Feb · Board meeting
Meeting on 2 Feb 2022
Jan 2022
10 Jan · Board meeting
Meeting on 18 Jan 2022: quarterly results
Nov 2021
8 Nov · Board meeting
Meeting on 19 Nov 2021
Oct 2021
19 Oct · Board meeting
Meeting on 27 Oct 2021: quarterly results
Sep 2021
18 Sep · Board meeting
13 Sep · Board meeting
Meeting on 18 Sep 2021: bonus issue
Aug 2021
17 Aug · Board meeting
Jul 2021
13 Jul · Board meeting
5 Jul · Board meeting
Meeting on 13 Jul 2021: quarterly results
May 2021
Apr 2021
19 Apr · Board meeting
Meeting on 3 May 2021: final dividend and audited results
Jan 2021
6 Jan · Board meeting
Meeting on 18 Jan 2021: quarterly results
Oct 2020
5 Oct · Board meeting
Meeting on 8 Oct 2020: half yearly results